Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV003408130 | SCV004123173 | likely benign | Hereditary thrombocytopenia and hematologic cancer predisposition syndrome | 2023-11-13 | reviewed by expert panel | curation | NM_001754.5(RUNX1):c.613+18G>C is an intronic variant. Evolutionary conservation prediction algorithms predict the site as not being conserved (PhyloP score 0.48 < 2.0 or the variant is the reference nucleotide in one primate and/or three mammal species) (BP7). Not a missense variant therefore REVEL score is not applicable and SpliceAI is <=0.50 (0.00) (BP4). In summary, this variant meets the criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4 and BP7 |
Labcorp Genetics |
RCV002124614 | SCV002409557 | benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2023-12-13 | criteria provided, single submitter | clinical testing |